Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Champlin

Showing results (171-180 of 279) with videos related to

Pageof 28
Sort By:
British Journal of Haematology|November 25, 2000
Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapyR Champlin, I Khouri, A Shimoni, et al.
Transfusion|May 1, 1997
Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastimP Anderlini, D Przepiorka, C Seong, et al.
Bone Marrow Transplantation|September 1, 2000
High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplantM de Lima, K van Besien, J Gajewski, et al.
Stem Cells (Dayton, Ohio)|September 30, 2000
Recombinant human thrombopoietin clinical developmentD V Jones, M Ashby, S Vadhan-Raj, et al.
Journal of Hematotherapy|October 1, 1996
Rapid debulking and CD34 enrichment of filgrastim-mobilized peripheral blood stem cells by semiautomated density gradient centrifugation in a closed systemD Przepiorka, P Van Vlasselaer, L Huynh, et al.
Cytotherapy|September 15, 2009
Debulking blood stem cell collections by density gradient centrifugation in a closed-vessel systemD Przepiorka, J G Lu, P Anderlini, et al.
Blood|May 23, 2001
Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donorsD Przepiorka, T L Smith, J Folloder, et al.
Blood|July 15, 1990
Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantationR Champlin, W Ho, J Gajewski, et al.
Transplantation Proceedings|February 1, 1991
Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemiaR Champlin, J Jansen, W Ho, et al.
Bone Marrow Transplantation|May 11, 2004
CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot studyE P Alyea, C Canning, D Neuberg, et al.
Pageof 28

Showing results (171-180 of 279) with videos related to

Sort By:
Pageof 28
British Journal of Haematology|November 25, 2000
Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapyR Champlin, I Khouri, A Shimoni, et al.
Transfusion|May 1, 1997
Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastimP Anderlini, D Przepiorka, C Seong, et al.
Bone Marrow Transplantation|September 1, 2000
High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplantM de Lima, K van Besien, J Gajewski, et al.
Stem Cells (Dayton, Ohio)|September 30, 2000
Recombinant human thrombopoietin clinical developmentD V Jones, M Ashby, S Vadhan-Raj, et al.
Journal of Hematotherapy|October 1, 1996
Rapid debulking and CD34 enrichment of filgrastim-mobilized peripheral blood stem cells by semiautomated density gradient centrifugation in a closed systemD Przepiorka, P Van Vlasselaer, L Huynh, et al.
Cytotherapy|September 15, 2009
Debulking blood stem cell collections by density gradient centrifugation in a closed-vessel systemD Przepiorka, J G Lu, P Anderlini, et al.
Blood|May 23, 2001
Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donorsD Przepiorka, T L Smith, J Folloder, et al.
Blood|July 15, 1990
Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantationR Champlin, W Ho, J Gajewski, et al.
Transplantation Proceedings|February 1, 1991
Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemiaR Champlin, J Jansen, W Ho, et al.
Bone Marrow Transplantation|May 11, 2004
CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot studyE P Alyea, C Canning, D Neuberg, et al.
Pageof 28